Grant D Stewart
Overview
Explore the profile of Grant D Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
4195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horvat-Menih I, Khan A, McLean M, Duarte J, Serrao E, Ursprung S, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002163
: Early and accurate grading of renal cell carcinoma (RCC) improves patient risk stratification and has implications for clinical management and mortality. However, current diagnostic approaches using imaging and renal...
2.
Bex A, Jewett M, Lewis B, Abel E, Albiges L, Berg S, et al.
Eur Urol
. 2025 Jan;
PMID: 39855942
Neoadjuvant systemic treatment strategies have improved outcomes in several solid tumour types. This success has not yet been replicated in renal cell carcinoma (RCC). A consensus and international collaboration are...
3.
Rossi S, Dombrowe V, Godfrey L, Bucaciuc Mracica T, Pita S, Milne-Clark T, et al.
Oncogene
. 2025 Jan;
PMID: 39824946
Clear cell renal cell carcinoma (ccRCC) is characterised by significant genetic heterogeneity, which has diagnostic and prognostic implications. Very limited evidence is available regarding DNA methylation heterogeneity. We therefore generate...
4.
Asciak L, Kyeremeh J, Luo X, Kazakidi A, Connolly P, Picard F, et al.
NPJ Digit Med
. 2025 Jan;
8(1):32.
PMID: 39815013
Computer-assisted surgery is becoming essential in modern medicine to accurately plan, guide, and perform surgeries. Similarly, Digital Twin technology is expected to be instrumental in the future of surgery, owing...
5.
Gao B, Kanabur P, Campi R, Tran M, Landman J, Pedrosa I, et al.
BJU Int
. 2025 Jan;
135(3):371-379.
PMID: 39761985
No abstract available.
6.
Nathan A, Gao C, Light A, Alexander C, Chan V, Gallagher K, et al.
BJUI Compass
. 2025 Jan;
5(12):1314-1323.
PMID: 39744074
Objectives: The objective of this study is to compare the early oncological outcomes of delayed (>90 days) versus scheduled (≤90 days) radical prostatectomy (RP). Patients And Methods: Patients with prostate...
7.
Meade A, Frangou E, Choodari-Oskooei B, Larkin J, Powles T, Stewart G, et al.
Contemp Clin Trials Commun
. 2024 Nov;
42:101381.
PMID: 39555240
Clinical trials to establish the efficacy of new agents in the adjuvant cancer setting typically take many years to complete. During that time, external factors can impact recruitment and reporting...
8.
Horvat-Menih I, McLean M, Zamora-Morales M, Wylot M, Kaggie J, Khan A, et al.
BMJ Open
. 2024 Oct;
14(10):e083980.
PMID: 39461869
Introduction: Localised renal masses are an increasing burden on healthcare due to the rising number of cases. However, conventional imaging cannot reliably distinguish between benign and malignant renal masses, and...
9.
Marandino L, Campi R, Amparore D, Tippu Z, Albiges L, Capitanio U, et al.
Eur Urol Oncol
. 2024 Sep;
PMID: 39327187
Context: Immune-oncology strategies are revolutionising the perioperative treatment in several tumour types. The perioperative setting of renal cell carcinoma (RCC) is an evolving field, and the advent of immunotherapy is...
10.
Pacyna C, Anandapadamanaban M, Loudon K, Hay I, Perisic O, Li R, et al.
Oncogene
. 2024 Sep;
43(44):3268-3276.
PMID: 39271965
Embryogenesis is a vulnerable time. Mutations in developmental cells can result in the wide dissemination of cells predisposed to disease within mature organs. We characterised the evolutionary history of four...